CLINICAL_TRIALS
trial_result
· 2014-10-10
Clinical Trial Update: A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. [Phase 4]
Summary
A Phase 4 study evaluating tamsulosin OCAS for nighttime voiding in men with benign prostatic hyperplasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED